Current Clinical Pharmacology

Editorial (Hot Topic: The New Kids on the Block: Oral Direct IIa and Xa Inhibitors Enter the Proscenium of Anticoagulation Treatment)
pp. 147-148(2)
Authors: Giannopoulos, Georgios; Deftereos, Spyridon

Novel Direct Factor IIa and Xa Inhibitors: Mechanisms of Action and Preclinical Studies
pp. 149-165(17)
Authors: Deftereos, Spyridon; Anatoliotakis, Nikolaos; Giannopoulos, Georgios; Kaoukis, Andreas; Mavri, Maria; Pyrgakis, Vlasios; Stefanadis, Christodoulos

Oral IIa and Xa Inhibitors for Prevention of Stroke in Atrial Fibrillation: Clinical Studies and Regulatory Considerations
pp. 166-174(9)
Authors: Deftereos, Spyridon; Tsounis, Dimitrios; Giannopoulos, Georgios; Kossyvakis, Charalampos; Panagopoulou, Vasiliki; Raisakis, Konstantinos; Stefanadis, Christodoulos

Prevention and Treatment of Venous Thromboembolism and Pulmonary Embolism: The Role of Novel Oral Anticoagulants
pp. 175-194(20)
Authors: Deftereos, Spyridon; Hatzis, Georgios; Kossyvakis, Charalambos; Bouras, Georgios; Panagopoulou, Vasiliki; Kaoukis, Andreas; Tousoulis, Dimitris; Stefanadis, Christodoulos

Novel Oral Anticoagulants in the Treatment of Acute Coronary Syndromes: Is there any Room for New Anticoagulants?
pp. 195-208(14)
Authors: Deftereos, Spyridon; Bouras, Georgios; Giannopoulos, Georgios; Kossyvakis, Charalambos; Panagopoulou, Vasiliki; Pyrgakis, Vlasios; Stefanadis, Christodoulos

An Aggressive Medical Approach for Inflammatory Bowel Disease: Clinical Challenges and Therapeutic Profiles in a Retrospective Hospital-based Series
pp. 209-213(5)
Authors: C. Actis, Giovanni; Rosina, Floriano; Pellicano, Rinaldo; Rizzetto, Mario

GLP-1 Agonists Exenatide and Liraglutide: A Review About Their Safety and Efficacy
pp. 214-228(15)
Authors: Derosa, Giuseppe; Maffioli, Pamela

Medical Treatment of Overactive Bladder: An Overview
pp. 229-239(11)
Authors: Gupta, Kanchan; Kaushal, Sandeep